≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of meninges, including Hilmo

Endpoint Browser PheWeb

C3_MENINGES_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C70
  • Hospital discharge: ICD-9 — 1921|1923
  • Hospital discharge: ICD-8 — 192[1-2]
  • Cause of death: ICD-10 — C70
  • Cause of death: ICD-9 — 1921|1923
  • Cause of death: ICD-8 — 192[1-2]
  • Cancer registry: Topography ICD-O-3 — C70
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

150

4. Check minimum number of events

None

150

5. Include endpoints

None

150

6. Filter based on genotype QC (FinnGen only)

134

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 134 82 52
Unadjusted period prevalence (%) 0.03 0.03 0.02
Median age at first event (years) 61.21 58.03 66.22

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
139
Matched controls
1390
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
+∞
88.1
75
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
29.5
80.6
63
38
H02AB02
ATC
dexamethasone; systemic
181.8
68.4
67
7
XX3DW
NOMESCO Finland
Time consuming IT work
23.6
52.7
42
25
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
164.3
44.9
45
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
17.6
40.7
37
28
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
172.6
37.9
38
*
130
Kela drug reimbursment
Malignant tumour
+∞
36.0
33
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
214.2
33.3
33
*
C70.9
ICD-10 Finland
Malignant neoplasm: Meninges, unspecified
+∞
32.6
30
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
25.8
24
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.9
25.4
52
111
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
24.7
23
*
ZXE20
NOMESCO Finland
More than three and less than five hours
7.1
24.1
46
91
N03AX14
ATC
levetiracetam; systemic
52.8
22.3
26
6
A04AA02
ATC
granisetron; systemic, transdermal
259.1
22.3
22
*
JN4BD
NOMESCO Finland
Extensive body CT
10.2
21.8
27
32
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
81.7
19.3
21
*
WF002
NOMESCO Finland
Radical radiotherapy
205.1
18.0
18
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
17.0
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
192.1
16.9
17
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
34.9
16.7
21
7
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
30.6
16.1
21
8
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
15.9
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.2
15.6
21
9
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
21.5
15.3
22
12
WZC00
NOMESCO Finland
Treatment plan or consultation
4.1
14.9
64
240
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
14.8
14
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
166.8
14.8
15
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
23.1
14.3
20
10
115
Kela drug reimbursment
Breast cancer
+∞
13.8
13
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.7
13.3
19
10
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.7
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.7
12
*
ZXC95
NOMESCO Finland
Use of surgical navigator
33.3
11.9
15
5
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
71.1
11.8
13
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.6
11
*
C70.1
ICD-10 Finland
Malignant neoplasm: Spinal meninges
+∞
11.6
11
*
N02AA05
ATC
oxycodone; systemic
4.1
11.6
39
120
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
11.3
39
122
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
11.3
68
307
A04AA01
ATC
ondansetron; systemic, rectal
13.5
11.2
19
16
Z51.5
ICD-10 Finland
Palliative care
9.8
11.0
22
26
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
23.8
10.9
15
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
17.9
10.6
16
10
L01AX03
ATC
temozolomide; systemic
+∞
10.5
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.5
10
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
10.5
10
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
12.0
10.1
18
17
AA1BD
NOMESCO Finland
Extensive CT of head and brain
16.6
9.8
15
10
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
107.0
9.5
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
9.5
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.5
9
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
9.5
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.5
9
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
9.5
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.5
9
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
9.5
9
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
39.5
9.2
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
9.0
45
178
WX402
NOMESCO Finland
General anaesthesia
3.4
8.9
40
148
N03AF02
ATC
oxcarbazepine; oral
12.8
8.8
15
13
L03AA13
ATC
pegfilgrastim; parenteral
95.6
8.5
9
*
L02BA01
ATC
tamoxifen; oral
95.6
8.5
9
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
95.6
8.5
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.1
8.4
17
21
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
8.3
28
85
XX2RW, ,
NOMESCO Finland
35.6
8.2
10
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
23.7
8.2
11
5
AA1AD
NOMESCO Finland
CT of head and brain
2.8
7.8
62
313
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.4
7.5
12
9
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
L03AA02
ATC
filgrastim; parenteral
+∞
7.4
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.4
7
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
7.4
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
7.4
7
*
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
+∞
7.4
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
7.4
7
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
7.3
20
52
ZX120
NOMESCO Finland
Intravenous
4.7
7.0
17
40
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
6.9
24
74
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.3
6.7
17
30
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
73.1
6.5
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
73.1
6.5
7
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
6.3
6
*
1921A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Cerebral meninges
+∞
6.3
6
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
6.3
6
*
JN4AD
NOMESCO Finland
Body CT examination
5.5
6.1
17
34

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
50
21
36.62
73.27
1.7
1.2
—
—
—
0
0
31
64
5.95
15.11
6.5
8.3
25.21
25.74
mmol/l
0.28
31
64
75
355
3.42
11.61
2.8
1.7
—
—
—
0
0
28
69
4.83
11.03
5.0
4.0
—
—
—
0
0
68
338
2.98
9.14
3.3
2.0
—
—
—
0
0
28
85
3.87
8.33
6.5
2.7
0.00
0.00
%
—
7
15
27
83
3.80
7.87
6.6
2.6
0.00
0.07
%
—
7
15
80
467
2.68
7.48
18.9
9.8
0.01
0.00
e9/l
0.65
72
372
27
87
3.61
7.33
6.8
2.6
1.36
0.68
%
—
7
19
25
78
3.69
7.11
6.6
2.7
0.43
0.29
%
—
7
17
57
299
2.54
6.42
6.6
4.0
—
—
—
0
0
34
137
2.96
6.40
6.9
6.3
2.01
1.85
mmol/l
0.11
29
121
61
335
2.46
6.19
3.5
3.0
0.30
0.45
e6/l
0.48
49
234
33
136
2.87
5.93
7.1
6.4
7.42
7.42
ph
0.07
23
84
10
10
10.66
5.63
1.6
1.0
—
—
—
0
0
66
388
2.33
5.62
3.8
3.2
20.70
207.77
e6/l
0.56
55
287
36
160
2.69
5.60
5.9
5.7
105.11
103.77
mmol/l
1.18
36
160
88
588
2.35
5.51
10.7
6.0
1.21
1.22
mmol/l
0.07
68
521
81
524
2.31
5.46
10.9
5.4
1.21
1.22
mmol/l
0.39
76
478
56
312
2.33
5.35
3.4
2.9
—
0.00
estimate
—
0
5
78
509
2.21
5.00
7.4
3.6
34.09
35.91
g/l
2.20
72
478
11
17
6.92
4.88
2.5
2.1
8.69
8.05
kpa
0.47
11
17
11
17
6.92
4.88
2.5
2.1
4.85
4.93
kpa
0.11
11
17
12
23
5.60
4.57
2.1
1.2
—
—
—
0
0
69
441
2.12
4.53
4.2
4.0
224.75
67.14
e6/l
0.80
57
300
74
486
2.12
4.52
3.9
2.3
—
—
estimate
—
0
0
42
224
2.25
4.32
8.8
3.6
—
—
—
0
0
85
595
2.10
4.31
16.2
5.7
4.48
4.28
e9/l
0.24
79
509
20
74
2.99
4.30
8.4
8.7
95.07
93.03
%
1.30
20
74
35
173
2.37
4.28
3.6
1.8
—
—
—
0
0
62
389
2.07
4.20
3.5
3.4
—
—
—
0
0
19
72
2.90
3.92
8.5
8.7
0.67
0.69
%
0.08
19
72
56
348
2.02
3.82
7.6
3.3
7.41
7.40
ph
0.94
43
243
12
30
4.28
3.69
2.5
2.9
7.41
7.41
ph
0.09
12
30
9
17
5.58
3.57
1.7
2.5
—
—
—
0
0
8
13
6.45
3.55
1.9
1.2
—
—
—
0
0
10
22
4.81
3.50
4.7
2.2
55.70
60.47
%
—
10
22
20
83
2.65
3.49
1.5
1.1
—
—
—
0
0
52
332
1.90
3.18
4.6
4.1
0.00
0.00
estimate
-0.00
37
92
8
16
5.23
3.10
4.0
2.4
3.36
5.04
e9/l
—
8
16
76
557
1.80
2.93
17.1
15.1
1.27
1.28
inr
0.04
68
467
6
9
6.90
2.89
2.2
2.2
—
—
—
0
0
48
321
1.76
2.43
8.7
4.4
—
—
—
0
0
74
564
1.67
2.29
9.3
4.8
0.64
0.59
e9/l
0.99
66
476
74
571
1.63
2.13
9.3
4.8
0.04
0.04
e9/l
0.32
66
481
49
343
1.66
2.06
5.6
3.2
0.00
0.00
estimate
-0.00
28
81
8
26
3.20
2.05
11.9
2.1
48.50
14.38
u/ml
—
8
21
9
32
2.93
2.04
4.8
2.2
121.89
190.88
mg/l
—
9
8
23
129
1.94
2.01
1.9
1.8
—
—
—
0
0
68
520
1.60
1.99
10.0
4.6
60.18
57.94
%
0.80
68
485
74
580
1.59
1.94
9.7
4.9
1.68
1.84
e9/l
1.12
68
505
67
515
1.58
1.89
3.5
4.2
15.95
32.56
ng/l
3.55
56
379
55
404
1.60
1.88
2.2
2.0
120.60
225.70
u/l
0.97
55
384
50
360
1.61
1.85
8.9
4.9
—
—
—
0
0
18
97
1.98
1.76
10.7
7.6
—
—
—
0
0
18
97
1.98
1.76
4.1
5.4
6.59
9.71
mmol/l
2.14
18
91
37
514
0.62
1.71
2.1
2.0
1.32
1.34
mmol/l
0.05
26
446
73
588
1.51
1.59
9.5
5.0
0.16
0.19
e9/l
1.12
66
505
61
479
1.49
1.47
4.6
3.7
0.00
0.06
estimate
0.78
24
86
78
647
1.47
1.41
4.4
3.9
0.00
0.05
estimate
0.64
36
98
102
1126
0.65
1.39
4.9
5.3
6.02
5.98
mmol/l
0.10
89
1027
5
18
2.84
1.29
1.2
1.2
—
—
—
0
0
98
1085
0.67
1.26
6.8
7.1
40.46
39.92
mmol/mol
0.27
89
1021
76
637
1.43
1.25
4.4
3.9
0.00
0.00
estimate
-0.00
38
106
13
71
1.92
1.24
3.3
3.7
—
—
—
0
0
75
629
1.42
1.22
4.4
3.8
0.00
0.00
estimate
-0.00
35
103
22
143
1.64
1.21
2.0
1.4
—
—
—
0
0
29
203
1.54
1.18
3.4
3.1
4.72
2.36
e6/l
0.30
13
92
17
105
1.71
1.12
2.6
2.7
1.74
0.35
e6/l
0.49
17
99
23
156
1.57
1.07
1.6
1.7
—
—
—
0
0
105
1132
0.70
0.94
4.8
6.2
2.68
2.62
mmol/l
0.26
92
1048
22
303
0.67
0.90
3.3
4.0
1.02
1.02
kg/l
0.27
12
206
10
57
1.81
0.86
3.6
3.7
36.84
36.91
°c
—
10
57
49
402
1.34
0.84
3.2
3.6
—
—
—
0
0
33
254
1.39
0.84
1.8
1.8
450.04
84286150.23
pmol/l
0.75
24
210
20
140
1.50
0.82
3.5
2.9
7.39
7.38
ph
—
9
81
35
276
1.36
0.77
1.5
1.3
—
—
—
0
0
89
805
1.29
0.72
4.6
4.4
—
—
—
0
0
24
180
1.40
0.71
1.5
1.2
—
—
—
0
0
13
86
1.56
0.69
3.3
1.4
—
—
—
0
0
104
1106
0.76
0.64
4.1
5.4
1.52
1.51
mmol/l
0.06
90
1021
37
440
0.78
0.58
2.6
3.2
8.14
7.22
mmol/l
0.67
28
364
6
35
1.75
0.58
2.3
3.8
—
—
—
0
0
10
65
1.58
0.57
1.9
2.6
—
—
—
0
0
37
438
0.79
0.56
3.4
3.9
14.08
8.19
mg/mmol
0.19
21
259
16
213
0.72
0.55
1.3
1.3
26.82
7.82
u/ml
—
9
72
99
1052
0.80
0.54
3.6
4.5
1.28
1.28
mmol/l
0.00
88
960
11
75
1.51
0.52
2.6
2.3
0.61
0.58
%
0.18
11
75
11
75
1.51
0.52
2.6
2.3
0.89
1.13
%
1.11
11
75
23
183
1.31
0.49
3.3
2.6
12.23
12.31
umol/l
0.02
23
174
31
257
1.27
0.49
2.0
1.7
1.12
1.17
mg/l
0.07
25
204
5
82
0.60
0.47
1.4
1.4
—
—
—
0
0
37
430
0.81
0.47
2.6
3.2
17.15
49.36
mg/l
2.43
22
258
116
1109
1.28
0.45
30.7
14.5
23.35
24.05
mg/l
0.11
109
899
106
1111
0.81
0.44
4.3
5.4
4.64
4.58
mmol/l
0.24
94
1034
8
56
1.45
0.43
1.0
1.3
—
—
—
0
0
5
31
1.64
0.43
2.2
1.6
0.17
0.21
g/l
—
5
31
5
32
1.58
0.42
2.0
1.6
1.07
1.09
g/l
—
5
32
0
15
0.00
0.41
0.0
1.5
—
252.96
—
0
15
96
904
1.20
0.41
4.9
4.3
14.75
14.92
pmol/l
0.27
88
829
35
403
0.82
0.40
1.6
1.8
20.16
21.17
nmol/l
0.14
30
346
8
61
1.33
0.40
1.6
1.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
19
231
0.79
0.36
1.4
1.3
51.86
26.31
iu/ml
—
8
73
6
43
1.41
0.35
1.0
1.2
—
—
—
0
0
6
45
1.35
0.34
4.0
3.5
1.47
1.13
mmol/l
—
6
45
16
129
1.27
0.32
1.5
1.3
—
—
—
0
0
25
214
1.21
0.30
2.1
1.7
1152.25
1133.12
nmol/l
0.03
16
163
7
56
1.26
0.30
1.0
1.1
—
—
—
0
0
5
37
1.36
0.24
3.2
4.0
3.98
3.88
mmol/l
—
5
37
5
39
1.29
0.23
3.8
1.6
—
—
—
0
0
5
41
1.23
0.22
1.6
1.6
—
—
—
0
0
8
103
0.76
0.22
2.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
5.60
—
0
5
0
11
0.00
0.21
0.0
1.3
—
8.23
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
109.70
—
0
10
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
0.54
—
0
7
0
12
0.00
0.21
0.0
1.1
—
291.83
—
0
6
18
155
1.19
0.21
7.6
4.5
0.88
1.02
mmol/l
1.23
18
140
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
9
115
0.77
0.20
1.7
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
3.1
—
600.44
—
0
9
0
14
0.00
0.20
0.0
1.0
—
1.20
—
0
7
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
1.86
—
0
7
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
8
71
1.13
0.16
1.3
1.6
—
—
—
0
0
6
80
0.74
0.16
1.8
2.0
3.33
3.55
mmol/l
—
6
60
20
182
1.12
0.12
4.7
2.8
0.84
0.82
ug/l
0.07
14
118
105
1070
0.92
0.11
5.9
5.5
2.23
1.90
mu/l
1.55
97
977
55
571
0.94
0.10
2.1
2.2
88.60
99.64
pmol/l
0.97
27
298
6
56
1.07
0.09
1.0
1.5
—
—
—
0
0
11
103
1.07
0.02
1.6
1.5
—
—
—
0
0
12
126
0.95
0.00
1.7
1.5
—
—
—
0
0
22
224
0.98
0.00
1.1
1.3
2.75
2.57
g/l
0.09
14
118
51
512
0.99
0.00
3.4
3.4
6.48
6.26
ph
0.53
27
278
36
363
0.99
0.00
3.7
2.9
—
0.18
—
0
11
0
5
0.00
-0.00
0.0
2.6
—
0.74
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
13.71
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
2186.67
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
50.41
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
7.84
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
128.80
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
25.00
—
0
5
7
79
0.88
-0.00
1.3
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
82.33
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MENINGES_WIDE – Malignant neoplasm of meninges, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).